Issued Patents 2011
Showing 1–25 of 30 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 8084583 | RS7 antibodies | Serengulam V. Govindan, Zhengxing Qu, Hans J. Hansen | 2011-12-27 |
| 8084029 | Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof | Hans J. Hansen, Zhengxing Qu | 2011-12-27 |
| 8080250 | Immunoconjugates with an intracellularly-cleavable linkage | Serengulam V. Govindan, Sung-Ju Moon | 2011-12-20 |
| 8076140 | Mammalian cell lines for increasing longevity and protein yield from a cell culture | Zhengxing Qu, Chien-Hsing Chang, Edmund A. Rossi, Jeng-Dar Yang, Diane Nordstrom | 2011-12-13 |
| 8067006 | Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites | Serengulam V. Govindan, Sung-Ju Moon, Chien-Hsing Chang | 2011-11-29 |
| 8062636 | Antibody therapy | Hans J. Hansen | 2011-11-22 |
| 8057793 | Anti-CD20 antibodies and fusion proteins thereof and methods of use | Hans J. Hansen, Zhengxing Qu | 2011-11-15 |
| 8038983 | Fluorinated carbohydrate conjugates | William J. McBride | 2011-10-18 |
| 8034352 | Tetrameric cytokines with improved biological activity | Chien-Hsing Chang, Edmund A. Rossi | 2011-10-11 |
| 8017736 | Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof | Hans J. Hansen, Zhengxing Qu | 2011-09-13 |
| 8003111 | Dimeric alpha interferon pegylated site-specifically shows enhanced and prolonged efficacy in vivo | Chien-Hsing Chang, William J. McBride, Edmund A. Rossi | 2011-08-23 |
| 7999083 | Immunoconjugates with an intracellularly-cleavable linkage | Serengulam V. Govindan, Sung-Ju Moon | 2011-08-16 |
| 7993626 | Methods and compositions for F-18 labeling of proteins, peptides and other molecules | William J. McBride, Christopher A. D'Souza | 2011-08-09 |
| 7981398 | PEGylation by the dock and lock (DNL) technique | Chien-Hsing Chang, William J. McBride, Edmund A. Rossi | 2011-07-19 |
| 7951369 | Chimeric, human and humanized anti-granulocyte antibodies and methods of use | Hans J. Hansen | 2011-05-31 |
| 7939073 | Immunotherapy of B-cell malignancies using anti-CD22 antibodies | — | 2011-05-10 |
| 7932212 | Inhibition of placenta growth factor (PlGF) mediated metastasis and/or angiogenesis | Alice P. Taylor, Chien-Hsing Chang | 2011-04-26 |
| 7931903 | Internalizing anti-CD74 antibodies and methods of use | Hans J. Hansen, Zhengxing Qu | 2011-04-26 |
| 7931890 | Targeted combination immunotherapy of cancer and infectious diseases | Gary L. Griffiths, Hans J. Hansen | 2011-04-26 |
| 7919090 | Antibody therapy | Hans J. Hansen | 2011-04-05 |
| 7919273 | Structural variants of antibodies for improved therapeutic characteristics | Chien-Hsing Chang, Hans J. Hansen | 2011-04-05 |
| 7919087 | Internalizing anti-CD74 antibodies and methods of use | Hans J. Hansen, Shui-on Leung, Zhengxing Qu | 2011-04-05 |
| 7914787 | Production and use of novel peptide-based agents with bispecific antibodies | Hans J. Hansen, William J. McBride | 2011-03-29 |
| 7910103 | Immunotherapy of B-cell malignancies using anti-CD22 antibodies | — | 2011-03-22 |
| 7906121 | Methods and compositions for generating bioactive assemblies of increased complexity and uses | Chien-Hsing Chang, William J. McBride, Edmund A. Rossi | 2011-03-15 |